Abstract

Much progress has been made in improving the viable cell density of bioreactor cultures in monoclonal antibody production from Chinese hamster ovary (CHO) cells; however, specific productivity (qP) has not been increased to the same degree. In this work, we analyzed a library of 24 antibody-expressing CHO cell clones to identify metabolites that positively associate with qP and could be used for clone selection or medium supplementation. An initial library of 12 clones, each producing one of two antibodies, was analyzed using untargeted LC-MS experiments. Metabolic model-based annotation followed by correlation analysis detected 73 metabolites that significantly correlated with growth, qP, or both. Of these, metabolites in the alanine, aspartate, and glutamate metabolism pathway, and the TCA cycle showed the strongest association with qP. To evaluate whether these metabolites could be used as indicators to identify clones with potential for high productivity, we performed targeted LC-MS experiments on a second library of 12 clones expressing a third antibody. These experiments found that aspartate and cystine were positively correlated with qP, confirming the results from untargeted analysis. To investigate whether qP correlated metabolites reflected endogenous metabolic activity beneficial for productivity, several of these metabolites were tested as medium additives during cell culture. Medium supplementation with citrate improved qP by up to 490% and more than doubled the titer. Together, these studies demonstrate the potential for using metabolomics to discover novel metabolite additives that yield higher volumetric productivity in biologics production processes.

Highlights

  • Chinese hamster ovary (CHO) cells are widely used for manufacturing of biopharmaceutical proteins, especially monoclonal antibodies

  • A metabolomics approach was used to identify CHO cell metabolites that are associated with productivity, cell growth, or both, across multiple clones producing different monoclonal antibodies (mAbs)

  • These metabolites were tested for their potential utility in cell culture process development either as a qP indicator or medium additive

Read more

Summary

Introduction

Chinese hamster ovary (CHO) cells are widely used for manufacturing of biopharmaceutical proteins, especially monoclonal antibodies (mAbs). CHO cell culture processes have gradually improved in volumetric productivity to reach recombinant protein titers on the order of 10 g/L in fed-batch production [1,2,3]. Much of the titer increases seen in the past few years have been due to increased viable cell density (VCD) and sustained viability [4,5]. Cell-specific productivity (qP) has improved to only a limited extent [6]. There is an urgent need to identify efficient strategies for developing high-producing clones and optimizing media or process conditions for VCD and qP

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call